Last reviewed · How we verify
Mucopolysaccharidosis, MPS-I
Approved treatments
- Aldurazyme · Genzyme, a Sanofi Company
- Aldurazyme · BioMarin
Aldurazyme breaks down abnormal sugar molecules in the body to treat Mucopolysaccharidosis I.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mucopolysaccharidosis, MPS-I patent landscape — cliff calendar, originator estates, attackable patents
- Mucopolysaccharidosis, MPS-I treatment landscape brief
- Mucopolysaccharidosis, MPS-I treatment updates RSS
Frequently asked questions about Mucopolysaccharidosis, MPS-I
What drugs treat Mucopolysaccharidosis, MPS-I?
Tracked treatments include Aldurazyme.
What is the treatment for Mucopolysaccharidosis, MPS-I?
Standard treatment for Mucopolysaccharidosis, MPS-I includes Aldurazyme. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mucopolysaccharidosis, MPS-I patent cliff · Mucopolysaccharidosis, MPS-I CI report
- Treatment: Aldurazyme · Genzyme, a Sanofi Company
- Treatment: Aldurazyme · BioMarin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing